Skip to content

Bringing Knowledge About Chronic Kidney Disease in Brazil: Filling the Gap

Cross-sectional Study to Evaluate the Chronic Kidney Disease Prevalence Using a Creatinine Point-of-care Tool in Brazilian Adult Patients With Known CKD Risk Factors Randomly Selected

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07103629
Acronym
Filling gap
Enrollment
8428
Registered
2025-08-05
Start date
2025-05-31
Completion date
2025-09-30
Last updated
2025-10-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal Insufficiency, Chronic

Keywords

chronic kidney disease

Brief summary

This is a multicenter cross-sectional study will randomly screen kidney function in adult patients with known risk factors for chronic kidney disease (CKD) within the Brazilian general population. Kidney function will be assessed using a point-of-care creatinine test at local healthcare facilities. Patients with abnormal test results will be referred for laboratory confirmation within three months and will undergo evaluation by the local nephrology team to determine the need for follow-up care.

Interventions

None listed

Sponsors

AstraZeneca
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Age \> 18 years old * At least one risk factor for CKD as mentioned above.

Exclusion criteria

* Patients with previous diagnosis of CKD * Patients younger than 18 years old * Patients unable to give informed consent to participate in the study.

Design outcomes

Primary

MeasureTime frameDescription
CKD potential prevalenceThrough study completation, an avarege 1 yearTo estimate the prevalence of Chronic Kidney Disease (CKD) in Brazil through random screening using a portable device for creatinine measurement and eGFR estimation in adult patients with risk factors for the development of CKD across the five regions of the country.

Secondary

MeasureTime frameDescription
Regional CKD potential prevalenceThrough study completation, an avarege 1 yearTo evaluate regional differences regarding CKD prevalence

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026